Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20071
20121
20133
20141
20151
20171
20181
20193
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
Novartis Pharmaceuticals3
Celgene1
Constellation Pharmaceuticals1
Fred Hutchinson Cancer Center1
Icahn School of Medicine at Mount Sinai1
Incyte Corporation1
Italfarmaco1
Janssen Research & Development, LLC1
Leukemia Research Fund1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders20
Primary Myelofibrosis9
Thrombocythemia, Essential7
Bone Marrow Diseases6
Leukemia6
Hematologic Diseases5
Polycythemia Vera5
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes4
Myelodysplastic-Myeloproliferative Diseases4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.